Molecular Assemblies, Inc.

DNA Synthesis Uncompromised

Founded 2013

San Diego, United States 4 employees Series B Total: $80.88M Biotechnology, Health Care

Molecular Assemblies, Inc., headquartered in San Diego, is at the forefront of the biotechnology and health care industries with its pioneering DNA Synthesis Uncompromised approach. Founded in 2013, the private life sciences company aims to revolutionize DNA synthesis using its proprietary technology, the Fully Enzymatic Synthesis (FES™). By emulating natural DNA synthesis processes, Molecular Assemblies offers solutions that are more reliable, affordable, and sustainable compared to traditional methods.

The company’s technology is poised to unlock new capabilities across various industries, including industrial synthetic biology and precision medicine. With potential applications in emerging fields like nanomachines and bio-based electronics, the impact is wide-ranging.

In August 2024, Molecular Assemblies secured a $4.00M grant from DARPA, affirming investor confidence in its cutting-edge approach. This investment positions Molecular Assemblies as a key innovator in the rapidly evolving landscape of DNA technology.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$4.00M	1	DARPA	01 Aug 2024
Series B	$25.80M	6	Casdin Capital, Argonautic Ventures +4	01 Mar 2022
Late VC	$20.13M	-		01 Sep 2021
Series A	$11.80M	6	Alexandria Venture Investments, Argonautic Ventures +4	01 Apr 2021
Series A	$12.20M	4	Alexandria Venture Investments, iSelect +2	01 Oct 2019
Seed	$4.50M	-		01 Aug 2017
Seed	$2.30M	-		01 Dec 2016
Grant	$150.00K	1	National Science Foundation	01 Nov 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$4.00M

DARPA

01 Aug 2024

Series B

$25.80M

Casdin Capital, Argonautic Ventures +4

01 Mar 2022

Late VC

$20.13M

01 Sep 2021

Series A

$11.80M

Alexandria Venture Investments, Argonautic Ventures +4

01 Apr 2021

Series A

$12.20M

Alexandria Venture Investments, iSelect +2

01 Oct 2019

Seed

$4.50M

01 Aug 2017

Seed

$2.30M

01 Dec 2016

Grant

$150.00K

National Science Foundation

01 Nov 2013

FAQ About Molecular Assemblies, Inc.

DNA Synthesis Uncompromised

Molecular Assemblies, Inc. was founded in 2013.

Molecular Assemblies, Inc. is headquartered in San Diego, United States.

Molecular Assemblies, Inc. operates in Biotechnology and Health Care. Its work centres on Enzymatic DNA Synthesis, Synthetic Biology, Precision Medicine and Industrial Synthetic Biology. Its customers include Clinical Medicine Researchers, Pharmaceutical Companies and Agricultural Scientists.

Molecular Assemblies, Inc. has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Usage Based.

Molecular Assemblies, Inc. has approximately 4 employees.

Molecular Assemblies, Inc. has completed 8 funding rounds, raising a total of $80.88M. The latest funding stage is Series B.

Molecular Assemblies, Inc. offers: Fully Enzymatic Synthesis (FES) of DNA, Long Oligonucleotide Production, In-process Purification.

Top alternatives and competitors to Molecular Assemblies, Inc. include Twist Bioscience, Synbio Technologies, DNA Script, Telesis Bio, Roswell . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Molecular Assemblies, Inc. and Twist Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Molecular Assemblies, Inc.

General Information

Discover More

About Molecular Assemblies, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (8)

Molecular Assemblies, Inc. Alternatives & Competitors

FAQ About Molecular Assemblies, Inc.